Earnings
NYSE
Nasdaq 100
U.S.
Tech
Politics
Science
AI
SEC
Business
Wall Street
Energy
Dow Jones
Bitcoin (BTC)
Dividend
Investing
NVIDIA (NVDA)
Markets
Economy
S&P 500
China
Donald Trump
World
Fed
Crude Oil
Money
Tesla (TSLA)
Inflation
Gold
Software
U.K.
Entertainment
Apple (AAPL)
Health
Retail
Wealth
Amazon (AMZN)
Taxes
Real Estate
Europe
Elon Musk
3M (MMM)
Natural Gas
Retirement
Microsoft (MSFT)
Security
Current
Meta Platforms (META)
Canada
Options
Truist Financial Corp (TFC)
Boeing (BA)
Jim Cramer
Tax
Hedge Funds
Insurance
Google
Sports
Live
Manufacturing
Cars
Economics
Pharmaceuticals
Mining
Costco (COST)
Airlines
Warren Buffett
War
Ukraine
Holidays
Japan
Construction
Silver
York
Finance
Interest Rates
Goldman Sachs (GS)
New York
BlackRock (BLK)
Kamala Harris
Walmart (WMT)
OpenAI
ChatGPT
REITs
Space
Mortgage
Internet
JPMorgan (JPM)
Ethereum (ETH)
Aerospace
Enterprise
Intel (INTC)
Walt Disney (DIS)
GBP USD
Netflix (NFLX)
India
Texas
Morgan Stanley (MS)
Australia
IPOs
More +
Market Insider
Stocks
ETFs
Bonds
Commodities
Earnings
Dividends
REITs
IPOs
Cryptocurrency
Forex
Tech
Politics
+
Pfizer (PFE) News
1 month
Penn Davis Mcfarland Inc. Takes Position in Pfizer Inc. (NYSE:PFE)
MarketBeat
X
1 month
1 Ultra-High-Yield Healthcare Stock to Buy Hand Over Fist and 1 to Avoid
The Motley Fool
X
1 month
Pfizer: Activists Clouding A Promising Picture
Seeking Alpha
X
1 month
Creative Planning Has $52.69 Million Holdings in Pfizer Inc. (NYSE:PFE)
MarketBeat
X
1 month
Pfizer Inc. (NYSE:PFE) Receives Average Rating of “Moderate Buy” from Analysts
MarketBeat
X
1 month
He Made Pfizer a Household Name. Wall Street Wants More.
Yahoo Finance
X
< Newer News